@FierceBiotech: JNJ teams with Scripps on a new Big Pharma/biotech spinoff matchmaking effort. Story | Follow @FierceBiotech
@JohnCFierce: Cytos hits self-destruct button as PhIIb asthma study bombs. More | Follow @JohnCFierce
@DamianFierce: Two biotech/med tech IPOs expected this week in Vital Therapies and TriVascular Technologies. Item | Follow @DamianFierce
@EmilyMFierce: Essential immune organ regenerated in mice. More | Follow @EmilyMFierce
> Eli Lilly ($LLY) and Boehringer Ingelheim have filed an NDA for a combination of empagliflozin and linagliptin for Type 2 diabetes. News
> Relypsa ($RLYP) is raising $88 million through a stock sale. Release
> Lexicon Pharmaceuticals ($LXRX) watched its shares jump nearly 20% on news that its diabetes candidate met its primary endpoint in a mid-stage trial. Article
> Alimera Sciences ($ALIM) and pSivida ($PSDV) are expected a final FDA decision on the thrice-rejected Iluvien by Sept. 26. More
@FierceMedDev: Varian Medical pays $35M to settle Pitt patent spat. News | Follow @FierceMedDev
@VarunSaxena2: ICYMI last week: Deerfield bets on robotic surgery with OMNIlife science deal. Article | Follow @VarunSaxena2
@EmilyWFierce: Staples wants to make 3D printing mainstream with a new trial program in New York and L.A. More from MedCity News | Follow @EmilyWFierce
@MichaelGFierce: ICYMI: 'Computer' made with DNA nanorobots delivers compounds in live cockroach. Story from FierceDrugDelivery | Follow @MichaelGFierce
> Abbott wins FDA nod for diabetes blood test. News
> Report: Covidien buys New Wave Surgical for $100M+. Article
> Edwards wins a battle in its ongoing TAVR patent war with Medtronic. Report
> Covidien snags FDA OK for a camera-equipped feeding tube. Item
Pharma News
@FiercePharma: Top-read FP news this weekend: PhRMA defends Gilead's pricey Sovaldi as docs look forward to more hep C choices. Story | Follow @FiercePharma
@TracyStaton: FiercePharma's best-read marketing story: Sanofi aims for outcomes with new Chief Patient Officer. More | Follow @TracyStaton
@EricPFierce: Daiichi Sankyo lays out the roadmap for finalizing the Ranbaxy and Sun deal. News | Follow @EricPFierce
@CarlyHFierce: Editor's Corner: Vivus needs more than boardroom shuffling to keep up with Arena's Belviq. Article | Follow @CarlyHFierce
> U.S. lawmakers join Lilly's attacks on Canada's patent attitude. News
> New attention disorder could equal a big new ADHD drug market. But is it legit? More
> Polish prosecutors hit GlaxoSmithKline with third round of bribery charges. Story
CRO News
> Clinipace cozies up to Karyopharm to get its pipeline moving. Story
> Parexel amps up its imaging focus in rebranded informatics biz. More
> Bristol-Myers enlists DKSH to push its drugs in Asia. Article
> Pacira picks Patheon to hit the gas on pain drug production. News
> Catalent inks a biosimilar alliance with a Chinese drugmaker. Report
> CROs are spending more on merit raises, survey says. Item
Biotech IT News
> PatientsLikeMe inks 5-year deal with Genentech. More
> Big Pharma companies open up cancer trial comparator arm data. Story
> Cheminformatics skills shortage threatens Indian drug discovery program. News
> Cancer foundation aiming to build a database of 50,000 human genomes. Report
> Pharma continues to grapple with trial participants' use of social media. Article
> NCI plans database of patients who experience miraculous recoveries. Item